Back to search
Schizophreniform Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophreniform Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophreniform Disorders trials you may qualify forThis is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.
The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizop…
Schizophrenia (SZ) affects approximately 4.5 million people across the European Union (EU) and is associated with annual healthcare and societal costs of 29 bil…
The goal of this clinical trial is to examine if iTBS applied to the DMPFC improves social cognitive performance compared to sham stimulation in people diagnose…
The participants in the study will receive psychiatric treatment at the UCLA Aftercare Research Program. All participants in this 12-month RCT will receive cogn…
The goal of this clinical trial is to compare the efficacy of combined REHACOP + MCT alone in persons with nonaffective psychotic disorder in terms of recovery.…
The purpose of this study is to understand how different types of community-based mental health care affect thinking abilities, daily functioning, and brain act…
The goal of this clinical trial is to learn more about decision making in psychosis spectrum disorders, like schizophrenia. Participants will be people who have…